Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01526512 | Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer | unknown | Phase 2 | 72 | Fudan UniversityOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00243685 |
| Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis |
| completed |
| Phase 2 / Phase 3 |
| 150 |
| Pierian BiosciencesINDUSTRY |
| 1 |
| Jan 26, 2012 |
| clinicaltrials |
| NCT00206466 | Biologic Correlative Taxotere/AC(TAX/AC) | completed | Phase 2 | 70 | Baylor Breast Care CenterOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT01254136 | Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer | terminated | Phase 1 / Phase 2 | 20 | Incyte CorporationINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT01483300 | Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT01292408 | Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients | unknown | Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00067314 | Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy | completed | Phase 2 | 65 | PfizerINDUSTRY | 4 | Jan 18, 2012 | clinicaltrials |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT01233947 | Study of AFP464 +/- Faslodex in ER + Breast Cancer | terminated | Phase 2 | 7 | Tigris PharmaceuticalsINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00448305 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | completed | Phase 2 | 143 | MediGeneINDUSTRY | 6 | Jan 5, 2012 | clinicaltrials |
| NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab(PGH) | completed | Phase 2 | 53 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01070706 | Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib(PGS) | completed | Phase 1 / Phase 2 | 15 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01169870 | Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients | withdrawn | Phase 2 | 0 | National Cancer Center, KoreaOTHER_GOV | 0 | Jan 4, 2012 | clinicaltrials |
| NCT01229605 | Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer | withdrawn | Phase 2 | 0 | Tufts Medical CenterOTHER | 0 | Dec 12, 2011 | clinicaltrials |
| NCT01100489 | Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00760370 | Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | completed | Phase 2 | 60 | Vejle HospitalOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00206505 | Neoadjuvant Taxotere | completed | Phase 2 | 40 | Baylor Breast Care CenterOTHER | 1 | Nov 17, 2011 | clinicaltrials |
| NCT01276769 | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer | unknown | Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT00028483 | Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | — | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT01451580 | Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 47 | TTY BiopharmINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00196820 | Mono Efficacy of Capecitabine (MoniCa) | completed | Phase 2 | 200 | GBG Forschungs GmbHOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01439191 | Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer | completed | Phase 2 | 109 | Shanghai CP Guojian Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 121 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT01422551 | Facilitating Positive Adaptation to Breast Cancer | completed | Phase 2 | 240 | University of MiamiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00795899 | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) | completed | Phase 2 | 230 | GBG Forschungs GmbHOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | unknown | Phase 2 / Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00602108 | Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 0 | Aug 10, 2011 | clinicaltrials |
| NCT00515762 | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling | completed | Phase 2 | 150 | Hospital San Carlos, MadridOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00028639 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00035841 | Phase 2 Study of TLK286 in Metastatic Breast Cancer | completed | Phase 2 | 60 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00471276 | Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer | completed | Phase 2 | 83 | PfizerINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00243503 | Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 5 | Jul 22, 2011 | clinicaltrials |
| NCT00927511 | A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)(FIDeS) | unknown | Phase 2 | 104 | Regina Elena Cancer InstituteOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01395706 | ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes | unknown | Phase 2 | 125 | Pulsion Medical Systems SEINDUSTRY | 1 | Jul 18, 2011 | clinicaltrials |
| NCT00629148 | Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00601159 | Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | completed | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01206881 | Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | completed | Phase 2 | 45 | Herlev HospitalOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01053468 | Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy(PROACTIVE) | unknown | Phase 2 | 150 | Athabasca UniversityOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 67 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00485979 | Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients(SATIN) | completed | Phase 2 | 330 | SanofiINDUSTRY | 8 | Jun 28, 2011 | clinicaltrials |
| NCT00532272 | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | Phase 2 | 78 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00532623 | Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 82 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00532285 | Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer | terminated | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00651417 | Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue | unknown | Phase 2 | 101 | Arizona Oncology ServicesOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00976365 | Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer | completed | Phase 2 | 60 | Taiwan THL Co.LTd.INDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Feb 7, 2012source: clinicaltrials